HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Beatrice Waser Selected Research

Somatostatin Receptors (Somatostatin Receptor)

4/2015Triple-peptide receptor targeting in vitro allows detection of all tested gut and bronchial NETs.
8/2014[111In-DOTA]LTT-SS28, a first pansomatostatin radioligand for in vivo targeting of somatostatin receptor-positive tumors.
6/2014The glucose-dependent insulinotropic polypeptide receptor: a novel target for neuroendocrine tumor imaging—first preclinical studies.
2/2014[DOTA]Somatostatin-14 analogs and their (111)In-radioligands: effects of decreasing ring-size on sst1-5 profile, stability and tumor targeting.
5/2012Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients.
2/2012Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors.
2/2012Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting.
12/2011Evaluation of 177Lu-DOTA-sst2 antagonist versus 177Lu-DOTA-sst2 agonist binding in human cancers in vitro.
7/2011PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
10/2010Absence of somatostatin SST(2) receptor internalization in vivo after intravenous SOM230 application in the AR42J animal tumor model.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Beatrice Waser Research Topics

Disease

54Neoplasms (Cancer)
08/2015 - 07/2002
13Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2015 - 12/2005
9Insulinoma
01/2015 - 05/2003
8Carcinoma (Carcinomatosis)
03/2015 - 07/2002
4Pheochromocytoma
08/2012 - 12/2004
3Neoplasm Metastasis (Metastasis)
01/2015 - 07/2002
3Breast Neoplasms (Breast Cancer)
01/2011 - 07/2002
3Ovarian Neoplasms (Ovarian Cancer)
01/2007 - 01/2004
3Paraganglioma (Paragangliomas)
12/2005 - 07/2003
3Neuroblastoma
12/2005 - 07/2003
2Adenocarcinoma
02/2014 - 02/2012
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
02/2012 - 02/2012
2Leiomyosarcoma
02/2012 - 08/2008
2Sarcoma (Soft Tissue Sarcoma)
08/2008 - 07/2003
2Gastrinoma
12/2006 - 05/2003
2Meningioma (Meningiomas)
12/2005 - 07/2003
2Medulloblastoma
12/2005 - 07/2003
2Pituitary Neoplasms (Pituitary Adenoma)
12/2005 - 07/2003
2Lung Neoplasms (Lung Cancer)
09/2004 - 07/2003
1Nesidioblastosis (Nesidioblastosis of Pancreas)
12/2015
1Prostatic Neoplasms (Prostate Cancer)
08/2015
1Pancreatic Ductal Carcinoma
01/2015
1Carcinoid Tumor (Carcinoid)
08/2012
1Leiomyoma (Uterine Fibroids)
02/2012
1Hepatocellular Carcinoma (Hepatoma)
02/2012
1Cholangiocarcinoma
02/2012
1Hyperplasia
01/2011
1Urologic Neoplasms (Urological Cancer)
06/2009
1Osteosarcoma (Osteogenic Sarcoma)
08/2008
1Chondrosarcoma
08/2008
1Hemangiosarcoma (Angiosarcoma)
08/2008
1Synovial Sarcoma (Synovioma)
08/2008
1Aggressive Fibromatosis (Desmoid)
08/2008
1Liposarcoma
08/2008
1Rhabdomyosarcoma
08/2008
1Lymphoma (Lymphomas)
05/2007
1Brain Neoplasms (Brain Tumor)
05/2007
1Glioma (Gliomas)
06/2006
1Glioblastoma (Glioblastoma Multiforme)
06/2006
1Wilms Tumor (Wilm's Tumor)
07/2005

Drug/Important Bio-Agent (IBA)

20Somatostatin Receptors (Somatostatin Receptor)IBA
04/2015 - 12/2002
18Peptide Receptors (Peptide Receptor)IBA
06/2015 - 07/2002
16Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2015 - 07/2002
13BombesinIBA
08/2015 - 07/2002
10Bombesin Receptors (Bombesin Receptor)IBA
08/2015 - 09/2004
8PeptidesIBA
10/2014 - 09/2004
7Glucagon-Like Peptide 1 (GLP 1)IBA
06/2014 - 05/2003
5Octreotide (Sandostatin)FDA LinkGeneric
05/2012 - 10/2006
5Neuropeptide YIBA
01/2011 - 01/2004
4Cholecystokinin B ReceptorIBA
06/2015 - 07/2003
4gastric inhibitory polypeptide receptorIBA
01/2015 - 01/2011
4Messenger RNA (mRNA)IBA
02/2012 - 07/2003
4Gastrin-Releasing PeptideIBA
07/2011 - 07/2002
4Neuropeptide Y Receptors (Neuropeptide Y Receptor)IBA
01/2011 - 01/2004
3IncretinsIBA
06/2014 - 01/2011
3LigandsIBA
09/2012 - 08/2008
3glucagon-like peptide receptor (receptor, glucagon-like peptide)IBA
02/2012 - 12/2006
2exenatide (Byetta)FDA Link
12/2015 - 12/2006
2NeurotensinIBA
01/2015 - 05/2011
2Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
02/2012 - 07/2003
2medullary Thyroid cancerIBA
08/2011 - 04/2011
2somatostatin receptor sst2AIBA
01/2010 - 12/2005
2NeuropeptidesIBA
08/2008 - 08/2005
2Peptide YYIBA
12/2004 - 01/2004
2Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
06/2004 - 07/2002
2Cholecystokinin (Pancreozymin)IBA
06/2004 - 07/2003
1alanyltyrosineIBA
08/2015
1minigastrinIBA
06/2015
1papillary Thyroid cancerIBA
03/2015
1Neurotensin Receptors (Neurotensin Receptor)IBA
01/2015
1tebufenozide (Mimic)IBA
08/2014
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
06/2014
1Serine Proteases (Serine Protease)IBA
06/2014
1GelatinIBA
06/2014
1NVP BEZ235IBA
08/2012
1secretin receptorIBA
08/2012
1somatostatin receptor type 1IBA
05/2012
1Glucose (Dextrose)FDA LinkGeneric
02/2012
1glucose receptorIBA
02/2012
1Biological Markers (Surrogate Marker)IBA
07/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2011
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2011
1neurotensin (9-13)IBA
05/2011
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
05/2011
1GastrinsIBA
04/2011
1Glutamic Acid (Glutamate)FDA Link
04/2011
1silicon fluorideIBA
12/2010
1pasireotideIBA
10/2010
1GTP-Binding Proteins (G-Protein)IBA
08/2009
1Cholecystokinin A ReceptorIBA
04/2009
1BoronIBA
09/2008
1DOTA-PEG(4)-bombesin (7-14)IBA
08/2007
1Pentetic Acid (DTPA)FDA LinkGeneric
12/2006
1Substance PIBA
06/2006
1Formaldehyde (Formol)FDA Link
12/2005
1AntibodiesIBA
12/2005

Therapy/Procedure

13Radiotherapy
01/2015 - 07/2002
4Heterologous Transplantation (Xenotransplantation)
10/2014 - 01/2012
1Boron Neutron Capture Therapy
09/2008
1Brachytherapy
06/2006